Generic Name and Formulations:
Netarsudil 0.02%; oph soln; contains benzalkonium chloride.
Aerie Pharmaceuticals, Inc.
Indications for RHOPRESSA:
Open-angle glaucoma. Ocular hypertension.
≥18yrs: Instill 1 drop into the affected eye(s) once daily in the PM.
<18yrs: not established.
Concurrent corneal disease or disruption of the ocular epithelial surface. Contact lenses (remove; may reinsert lenses 15mins after administration). Pregnancy. Nursing mothers.
Rho kinase inhibitor.
Allow at least 5mins between application of other topical oph agents.
Conjunctival hyperemia, corneal verticillata, instillation site pain, conjunctival hemorrhage; bacterial keratitis.